Industry Showcase Clozapine RE(MS)defined: Enhancing Psychiatric Pharmacy Practice with Therapeutic Drug Monitoring and Updated Guidelines Supported by Saladax Biomedical
This workshop will explore the pending changes in Clozapine REMS, providing psychiatric pharmacists with essential knowledge on the appropriate use of clozapine and the critical role of the therapeutic drug monitoring (TDM) in optimizing patient outcomes. Participatns will gain practical insights into navigating regulatory updates and enhancing clinical decision-making.
Explain the pending changes in the Clozapine REMS program and their implications of psychiatric pharmacy practice.
Identify clinical scenarios where clozapine is the preferred treatment and describe its unique role in managing treatment-resistant schizophrenia and reducing suicidal behavior in patients with schizophrenia.
Discuss the importance of TDM in clozapine therapy, its rapid results, and how to interpret levels and adjust dosages to optimize efficacy and safety.
Develop strategies to integrate updated REMS requirements and TDM protocols into pharmacy workflows to ensure compliance and improve patient care.
Evaluate case studies to illustrate how the use of clozapine, informed by TDM, leads to better therapeutic outocmes for patients with complex psychiatric needs.
Megan Ehret, PharmD, MS, BCPP, FAAPP
Professor
Co-Director of Mental Health Program
Vice-Chair of Academic Affairs
Department of Practice, Sciences, and Health Outcomes Research
University of Maryland School of Pharmacy
Deanna L. Kelly, PharmD, BCPP
Dr. William and Carol Carpenter Professor in Psychiatry for Mental Illness Research
Acting Director, Maryland Psychiatric Research Center
Chief, Treatment Research Program (TRP)
University of Maryland School of Medicine
Robert O. Cotes, MD, DFAPA
Professor and Distinguished Physician
Co-Director, Clinical and Research Program for Psychiatric and Behavioral Sciences
Emory University School of Medicine
Editor-in-Chief, Community Mental Health Journal
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
A modern web browser with JavaScript and cookies enabled: Chrome is strongly recommended,
or the latest version of Firefox or Safari.
A PDF reader: Chrome built-in, Firefox built-in, Acrobat
or FoxIt
An adequate device and Internet connection:
Processor: Dual-core 2Ghz or higher (Intel i3/i5/i7 or AMD equivalent);
Memory: 4 GB;
Storage: 5 GB available;
Internet speed: 4.0 Mbps (up/down)
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Grant Support
Supported by Saladax Biomedical
AAPP websites use cookies to personalize and enhance your experience.
By continuing to use the site, you agree to this collection.
Learn more.
